Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Congenital viral infections with enteroviruses (EV) including coxsackie viruses and ECHO viruses is an infectious embryofetopathy that have been reported to cause spontaneous abortion, stillbirth, fetal malformations and acute systemic illness in the newborn.
Features include very common findings: Skin rash; and common findings: Nervous system problems (abnormality of the nervous system), Irritability, Meningitis, and Low platelet count (thrombocytopenia) and others. 39 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 7 | Low platelet count (thrombocytopenia), Decreased total neutrophil count, Low white blood cell count (decreased total leukocyte count) |
Phenotype severity distribution: 1 very common feature, 8 common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for congenital enterovirus infection.
14 publications have been identified in PubMed for congenital enterovirus infection. Research spans Case Report / Case Series (29%), Epidemiology / Natural History (29%), and Review / Meta-Analysis (21%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 29% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:05 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about congenital enterovirus infection
Digestive system | 5 | Abnormality of the digestive system, Cholestasis, Hepatic failure |
Brain and nerves | 4 | Nervous system problems (abnormality of the nervous system), Irritability, Meningitis |
Pregnancy and birth | 4 | Decreased fetal movement, Hydrops fetalis, Fetal ascites |
Lungs and breathing | 3 | Abnormality of the respiratory system, Respiratory distress, Pleural effusion |
Skin | 2 | Skin rash, Abnormal skin morphology |
Heart and blood vessels | 2 | Heart muscle disease (cardiomyopathy), Pericardial effusion |
Metabolism | 1 | Fever |
Disease patterns and progression
4 |
29% |
Research summaries | 3 | 21% |
Clinical study results | 2 | 14% |
Laboratory research | 1 | 7% |
Abdulaal H (2026). [PMID: 41953453](https://pubmed.ncbi.nlm.nih.gov/41953453/). *Respir Med Case Rep*. [Case Report / Case Series]
Sharma K (2026). [PMID: 41645095](https://pubmed.ncbi.nlm.nih.gov/41645095/). *BMC Infect Dis*. [Basic Science / Preclinical]
Radia K (2026). [PMID: 41690287](https://pubmed.ncbi.nlm.nih.gov/41690287/). *Vaccine*. [Clinical Trial Publication]
Nguyen-Tran H (2026). [PMID: 40782819](https://pubmed.ncbi.nlm.nih.gov/40782819/). *Lancet Infect Dis*. [Epidemiology / Natural History]
Cameron JR (2026). [PMID: 41946354](https://pubmed.ncbi.nlm.nih.gov/41946354/). *Am J Trop Med Hyg*. [Epidemiology / Natural History]
Halouani A (2026). [PMID: 41931400](https://pubmed.ncbi.nlm.nih.gov/41931400/). *Rev Med Virol*. [Review / Meta-Analysis]
Feeney SA (2025). [PMID: 40444373](https://pubmed.ncbi.nlm.nih.gov/40444373/). *Euro Surveill*. [Case Report / Case Series]
Sotelo-de Jesús SD (2025). [PMID: 41037715](https://pubmed.ncbi.nlm.nih.gov/41037715/). *Rev Alerg Mex*. [Case Report / Case Series]
Agimas MC (2024). [PMID: 39645273](https://pubmed.ncbi.nlm.nih.gov/39645273/). *BMJ Open*. [Epidemiology / Natural History]
Longo C (2024). [PMID: 39201064](https://pubmed.ncbi.nlm.nih.gov/39201064/). *J Clin Med*. [Review / Meta-Analysis]
AI-curated news mentioning congenital enterovirus infection
Updated Mar 12, 2026
A study published in PubMed examines the post-marketing surveillance of adverse events related to the enterovirus type 71 inactivated vaccine in China from 2016 to 2023. The findings contribute to understanding the vaccine's safety profile in the population.